| Cerebral Venous Sinus Thrombosis | Lifetime | 58 | CN 3 | 98.93 |
| Acute Ischemic Stroke Management | Lifetime | 235 | CN 4 | 99.24 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 271 | CN 14 | 98.96 |
| Thermal Regulation in Medicine | Lifetime | 70 | CN 2 | 98.48 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 135 | CN 7 | 98.75 |
| Cardiac Ischemia and Reperfusion | Lifetime | 190 | CN 8 | 98.53 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 152 | CN 5 | 98.36 |
| Anesthesia and Neurotoxicity Research | Lifetime | 247 | CN 14 | 98.21 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 506 | CN 8 | 98.51 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 606 | CN 12 | 98.44 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 876 | CN 7 | 97.84 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 378 | CN 23 | 97.21 |
| Stroke Rehabilitation and Recovery | Lifetime | 967 | CN 35 | 96.88 |
| Neurological Complications and Syndromes | Lifetime | 726 | CN 23 | 90.04 |
| Barrier Structure and Function Studies | Lifetime | 889 | CN 39 | 86.07 |
| Moyamoya disease diagnosis and treatment | Lifetime | 931 | CN 85 | 86.42 |
| Cerebral Venous Sinus Thrombosis | 2021-2025 | 4 | CN 1 | 99.42 |
| Acute Ischemic Stroke Management | 2021-2025 | 47 | CN 8 | 99.49 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 12 | CN 3 | 97.86 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 49 | CN 13 | 98.60 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 8 | CN 2 | 97.67 |
| Traumatic Brain Injury and Neurovascular Disturbances | 2021-2025 | 63 | CN 1 | 98.76 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 36 | CN 9 | 98.35 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 126 | CN 16 | 98.27 |
| Stroke Rehabilitation and Recovery | 2021-2025 | 128 | CN 25 | 97.62 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 153 | CN 6 | 98.20 |
| High Altitude and Hypoxia | 2021-2025 | 19 | CN 1 | 96.85 |
| Thermal Regulation in Medicine | 2021-2025 | 17 | CN 3 | 95.28 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 63 | CN 19 | 94.56 |
| Vascular Malformations Diagnosis and Treatment | 2021-2025 | 86 | CN 5 | 96.10 |
| Mitochondrial Function and Pathology | 2021-2025 | 478 | CN 67 | 90.62 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 142 | CN 17 | 87.85 |
| Intracranial Aneurysms: Treatment and Complications | 2021-2025 | 782 | CN 155 | 88.42 |
| Neurological Complications and Syndromes | 2021-2025 | 136 | CN 24 | 84.20 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 311 | CN 4 | 83.51 |
| Autophagy in Disease and Therapy | 2021-2025 | 993 | CN 484 | 81.41 |
| Barrier Structure and Function Studies | 2021-2025 | 188 | CN 37 | 77.56 |
| Cardiovascular and Diving-Related Complications | 2021-2025 | 331 | CN 44 | 75.54 |
| Folate and B Vitamins Research | 2021-2025 | 766 | CN 213 | 70.94 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 494 | CN 165 | 70.79 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 623 | CN 259 | 66.61 |
| Traditional Chinese Medicine Analysis | 2021-2025 | 995 | CN 876 | 60.73 |
| Saffron Plant Research Studies | 2021-2025 | 705 | CN 143 | 18.59 |
